COPD
Adherence to action plan reduces COPD exacerbation recovery time
Thursday, January 13th, 2011Source: MedWire News
Patients with chronic obstructive pulmonary disease (COPD) can minimize their recovery time after an exacerbation by sticking to a written action plan, research shows.
Writing in the journal Thorax, Jean Bourbeau (McGill University Health Centre, Montréal, Canada) and team explain: “Despite the huge impact [COPD] exacerbations may have, patients often have problems in recognising symptom [...]
Long-term LABA treatment ‘does not increase CV events in COPD’
Monday, August 16th, 2010Source: MedWire News
Long-term treatment with long-acting β2-agonists (LABAs) does not increase the risk for cardiovascular (CV) events in patients with chronic obstructive pulmonary disease (COPD), research suggests.
Writing the journal Thorax, Peter Calverley (University Hospital Aintree, UK) and colleagues explain: “Recently there has been concern that the long-term use of inhaled bronchodilators commonly used in the treatment [...]
Asthma, COPD linked to reduced BMD, fractures in men
Sunday, July 11th, 2010Source: MedWire News
Asthma and chronic obstructive pulmonary disease (COPD) are independently associated with reduced bone mineral density (BMD) and an increased risk for fractures in men, study results show.
“A history of COPD or asthma may be a useful clinical risk factor to identify patients with osteoporosis,” suggest Thuy Dam (Columbia University, New York, USA) and [...]
Medication adherence poor in COPD patients
Friday, March 12th, 2010Source: MedWire News
Adherence to respiratory medications is poor among patients with chronic obstructive pulmonary disease (COPD), say researchers who suggest that measures such as simplification of dosing regimens should be implemented where possible.
Eric Van Ganse (University Hospital Lyon, France) and team investigated respiratory medication adherence and correlates of accidental and intentional treatment interruptions in 179 [...]
Tiotropium may reduce mortality in COPD patients
Monday, January 11th, 2010Treatment with the long-acting anticholinergic tiotropium is associated with reduced all-cause and cardiovascular (CV)-related mortality in patients with chronic obstructive pulmonary disease (COPD), results from a systematic review show.
Bartolome Celli (Brigham and Women’s Hospital, Boston, Massachusetts, USA) and colleagues reviewed safety data from 30 randomized, double-blind, parallel-group, placebo-controlled clinical trials of tiotropium with a duration [...]
